Systemic Mastocytosis: Understanding Mast Cell Activation and Its Impact
- Harold Pierre, MD
- Jun 11
- 7 min read
Updated: Jul 24
For many, the trouble begins with a collection of confusing symptoms—unpredictable allergic-like reactions, persistent bone pain, stomach issues, and a deep fatigue that never seems to go away. If this sounds familiar, you may be on what many call a "diagnostic odyssey," searching for answers that tie these seemingly unrelated problems together. One possible, though uncommon, answer is systemic mastocytosis, a condition caused by the body's mast cell. Understanding this complex rare disorder is the first step toward managing its symptoms and improving your quality of life.
As a board certified anesthesiologist and addiction medicine specialist, it may seem like systemic mastocytosis (SM) is a disease completely out of my specialty. But that is far from the case. Remember, whether the patient is healthy or has a rare disease, chances are they will need surgery. That's where my knowledge of the disease process becomes critical. Not only do I have to guide them safely through surgery, I have to manage their pain, and for those addicted to substances, I have to walk a tight-rope managing withdrawal symptoms that may trigger mast cell activation.
I wrote this simplified guide to explain the science behind systemic mastocytosis and mast cell activation, the symptoms and causes of this systemic mast cell activation disease, and the most current approaches to diagnosis and treatment.
The Role of the Mast Cell: The Body's First Responder
What is a mast cell?
A mast cell is a special type of white blood cell and a critical part of your immune system. They are found in tissues throughout the body, especially in places that interact with the outside world, like the skin, airways, and the gastrointestinal tract. The primary role of mast cells is to stand guard. When they detect a threat, they activate in a process called mast cell degranulation. Degranulated mast cells release a flood of powerful chemicals, including histamine and tryptase, which are responsible for the classic signs of an allergic reaction.
Histamine binds to receptors (H1 and H2) causing the blood vessels to become "leaky" allowing more blood to flow to the area. It is fast acting. This causes the classic redness, swelling, hives, and drop in blood pressure. Histamine also activate pain pathways causing itching and pain. In the lungs, it causes constriction leading to wheezing. In the stomach, it signals the parietal cells to release more acid causing heartburn, reflux and ulcers.
Tryptase is a protease which are enzymes that break down protein. It is slow acting. Tryptase activates other immune cells and contributes to the chronic inflammation, tissue damage, and clotting abnormalities. Of particular note, tryptase stimulates the osteoclast cells to breakdown bone.
While histamine and tryptase are just 2 of many chemicals mast cells release, understanding what these chemicals do will help you understand everything else we are about to discuss.
Systemic Mastocytosis: When Mast Cells Cause Problems
What are the signs and symptoms of the disease?
Systemic mastocytosis (SM) is a rare blood disorder where the body produces a higher number of mast cells due to a genetic change in a stem cell in the bone marrow. More than 90 % of cases are driven by the KIT D816V mutation (a tyrosine-kinase gain-of-function). In other cases, the PDGFRA (Platelet-Derived Growth Factor Receptor Alpha) mutation is the problem. In SM excess mast cells accumulate in various organs, and this mast cell infiltration can cause inflammation and a wide range of symptoms and complications.
Common Signs and Symptoms:
Skeletal Involvement: The involvement of mast cells in bone is highly common(20-40% of adults with SM), leading to osteoporosis, focal spots of bone loss (osteolysis), dense bone spots (osteosclerosis), or veterbal fractures in up to 39% of people.
Gastrointestinal (GI) Issues: GI symptoms are extremely common. They can be divided into two main types:
Peptic Symptoms: The release of histamine in the stomach can increase acid production, leading to heartburn, acid reflux, and peptic ulcers.
Mediator-Related Symptoms: Nausea, chronic abdominal pain, irritable bowel syndrome, and loose stools that occur within minutes to hours of a trigger (like a certain food) are classic signs of mast cell activation in the gut.
Skin Involvement: Many people experience skin lesions, a condition known as maculopular cutaneous mastocytosis.
Allergic Reactions: Unpredictable and severe allergic reactions (anaphylaxis) can occur.
Pain Conditions: Chronic pain is a major feature, manifesting as bone pain, joint pain, and muscle pain. This inflammatory pain makes the maintenance of pain a central challenge. It can also be a factor in conditions like osteoarthritis pain or chronic pelvic pain syndrome.
Constitutional Symptoms: Profound fatigue, brain fog, headaches (sometimes contributing to migraine pathology), and chest pain are very common.
Splenic involvement: About 5–10 % of indolent (silent) cases and up to 40–60 % of advanced cases develop an enlarged spleen (splenomegaly). Mild enlargement is often silent, but a stretched capsule can cause a dull ache or early satiety under the left ribs.
How SM Differs from MCAS and HαT
Before looking at diagnosis, it's important to understand how Systemic Mastocytosis (SM) differs from other mast cell conditions that cause similar symptoms.
SM vs. MCAS: While both conditions involve mast cell activation, the cause is different. In Mast Cell Activation Syndrome (MCAS), a normal number of mast cells are simply too reactive. In SM, the problem is a proliferative one—the body produces too many abnormal mast cells. [Read our detailed guide on managing chronic pain in MCAS here.]
SM vs. HαT: Many people have elevated tryptase due to a common genetic trait called Hereditary alpha-Tryptasemia (HαT) while mastocytosis is a rare disease. However, HαT is not a proliferative disease and does not involve an excess of mast cells. A doctor must rule out SM when investigating elevated tryptase, as HαT does not typically cause the severe bone disease seen in SM. [Learn more about the diagnosis and symptoms of HαT here.]
How Doctors Diagnose Systemic Mastocytosis
A Real-World Example: The Case of the Young Man with Back Pain
Consider a recent case report. A 23-year-old man sought help for severe back pain. Imaging revealed multiple vertebral fractures caused by severe osteoporosis. This major red flag prompted doctors to dig deeper. They found he had elevated mast cell tryptase levels and a high level of CTx, a blood marker that indicates rapid bone breakdown.
What is CTx? A Simple Explanation
CTx, a blood test that measures C-terminal telopeptide of type I collagen, measures the speed of bone breakdown. Think of your skeleton as a brick wall being remodeled by a demolition crew (osteoclast) and a construction crew (osteoblast). CTx is like the dust and rubble from the demolition. A high CTx level means bone is being broken down much faster than it's being rebuilt.
For the patient, the combination of high tryptase and high CTx was the critical clue pointing to systemic mastocytosis. This led to a bone marrow biopsy, which confirmed the diagnosis.
The Diagnostic Toolkit
When to Suspect SM: Doctors should suspect the condition in cases of unexplained osteoporosis (especially in young men), bone loss that resists treatment, or osteoporosis appearing with allergic-type symptoms.
Blood Tests and Imaging: The process often starts with blood tests for tryptase and CTx. Imaging like DXA (bone density) scans, X-rays, and CT scans are used to assess bone health.
Endoscopy: For patients with prominent GI symptoms, an endoscopy or colonoscopy with biopsies can be used to look for the characteristic aggregates of mast cells in the gastrointestinal tract.
Bone Marrow Biopsy: The biopsy remains the definitive test for diagnosis.
Treatment Options: How to Manage Symptoms and the Disease
There is no one-size-fits-all approach to treat systemic mastocytosis. The goal is to create a personalized plan to manage symptoms and control the disease.
Managing a Systemic Disease
Protecting Skeletal Health: For osteoporosis without fractures, bisphosphonates (like IV zoledronic acid) are often used. For severe cases with fractures, a combination of interferon alfa-2a and pamidronate has been shown to be highly effective.
Managing Gastrointestinal Symptoms:
H2 blockers (like famotidine) can be used to reduce stomach acid and help with peptic symptoms.
Oral cromolyn sodium, a mast cell stabilizer, is often very effective for mediator-driven symptoms like cramping and diarrhea.
Dietary modification is crucial. Identifying and avoiding food triggers can significantly improve symptoms. Working with a dietitian is often necessary to ensure a well-balanced diet.
Epinephrine auto-injector is another crucial medication in anaphylaxis
General Symptom Control: Antihistamines are a mainstay of therapy. For acute and chronic pain, acetaminophen is often better tolerated than NSAIDs.
Targeted Disease-Modifying Therapies
The biggest breakthrough has been the development of drugs that target the underlying mast cell dysfunction.
Avapritinib (AYVAKIT) is highly effective for patients with the KIT D816V mutation and has also shown efficacy in those without it.
Other promising drugs like bezuclastinib and elenestinib are in clinical trials for indolent systemic mastocytosis (ISM) and are showing positive results.
A Critical Takeaway
Living with systemic mastocytosis requires a strong partnership with a multidisciplinary medical team. The most important message is that this rare disorder must be considered in any patient presenting with unexplained osteoporosis, chronic gastrointestinal issues, or recurrent, severe allergic-type reactions. Early and accurate diagnosis is the key to managing this complex but often treatable condition.
I hope you found value in this article. To learn more, start with the Mast Cell Disease Society
Crupi, F., Caroprese, J., & Mannelli, F. (2025). Defining “Normal” basal serum tryptase levels: a context-dependent approach to improve diagnostics in systemic mastocytosis. Frontiers in Allergy, 6. https://doi.org/10.3389/falgy.2025.1592001
Degboé, Y., Nezzar, C., Alary, P., Maëva, M., Livideanu, C. B., & Laroche, M. (2025). Management of Bone Health in Adult Mastocytosis. Current Osteoporosis Reports, 23(10). https://doi.org/10.1007/s11914-025-00901-w
Kalfoutzou, A., Spanou, K., Mylonakis, A., Lagopoulou, V., Dimitrakoudi, M., Korovila, A., Piperis, C., Tsiouri, E., & Mostratou, E. (2025). Breaking point: Systemic mastocytosis manifesting as severe osteoporosis. Oncoscience, 12.
Hamilton, M. J. (2023). Gastrointestinal Disease in Mastocytosis. Immunology and Allergy Clinics of North America, 43(4), 711-722. https://doi.org/10.1016/j.iac.2023.04.005
About the author:
Harold Pierre, MD, is a board-certified anesthesiologist, board-certified addiction medicine specialist, and a concierge addiction doctor based out of Tulsa, Oklahoma with over 26 years of experience. He is board-certified by the American Board of Anesthesiology and the American Board of Preventive Medicine, and has extension experience managing hormones, pain, addiction, and their intersection. He is licensed in Florida, Texas, Oklahoma, South Carolina, Louisiana, and Arizona. If you are seeking care, you may schedule an appointment with him by calling or texting 918-518-1636. LinkedIn
*Disclaimer: This blog post is for informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of your doctor or other qualified health provider with any questions you may have regarding your health or a medical condition before making any changes. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
Comments